RPT-ORNA THERAPEUTICS ESTABLISHES STRATEGIC COLLABORATION WITH VERTEX PHARMACEUTICALS TO DEVELOP NEXT GENERATION APPROACHES FOR SICKLE CELL DISEASE (SCD) AND TRANSFUSION-DEPENDENT BETA THALASSEMIA (TDT)

Reuters · 01/07 12:10

Please log in to view news